Background: Chemotherapy-related cognitive impairment refers to a cluster of symptoms commonly referred to as “chemobrain”. To date, nursing literature on the progression of and tools used to evaluate chemobrain is limited. Objectives: The purpose of this pilot study was to explore the onset of...

Checkpoint inhibitors are a form of immunotherapy that have revolutionized treatment for malignant melanoma, resulting in longer survival and better disease control. Multiple autoimmune disorders can occur with the use of checkpoint inhibitors, including severe, potentially fatal neurologic...

Background: Managing cancer-related cognitive impairment (CRCI) is a vital component of optimal cancer survivorship care. Results from several small studies indicate growing support for the use of cognitive rehabilitation and training strategies. Objectives: This study aimed to retrospectively...